New spray chemotherapy trial offers hope for advanced pancreatic cancer patients
NCT ID NCT07253662
First seen Dec 16, 2025 · Last updated May 16, 2026 · Updated 20 times
Summary
This early-phase trial tests a new way to deliver chemotherapy directly to the abdomen using a pressurized spray, called PIPAC, in people with pancreatic cancer that has spread to the lining of the belly. The goal is to see if this approach is safe and tolerable when combined with standard treatments. Ten adults with this condition will receive the therapy, and researchers will monitor for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOCARCINOMA PANCREAS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zuckerberg Cancer Center
RECRUITINGNew Hyde Park, New York, 11040, United States
Conditions
Explore the condition pages connected to this study.